You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

Hetero Labs Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for HETERO LABS, and what generic and branded alternatives to HETERO LABS drugs are available?

HETERO LABS has one hundred and thirty-one approved drugs.

There are nine tentative approvals on HETERO LABS drugs.

Summary for Hetero Labs

US Patents:	0
Tradenames:	106
Ingredients:	104
NDAs:	131
Patent Litigation for Hetero Labs:	See patent lawsuits for Hetero Labs

Drugs and US Patents for Hetero Labs

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hetero Labs Ltd Iii	NAPROXEN	naproxen	SUSPENSION;ORAL	215776-001	Jun 7, 2022	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Hetero Labs Ltd V	LAMIVUDINE AND ZIDOVUDINE	lamivudine; zidovudine	TABLET;ORAL	203259-001	Feb 3, 2014	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Hetero Labs Ltd Iii	STAVUDINE	stavudine	CAPSULE;ORAL	078957-002	Dec 29, 2008		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Hetero Labs Ltd V	ATORVASTATIN CALCIUM	atorvastatin calcium	TABLET;ORAL	214344-001	Sep 12, 2023	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Hetero Labs Ltd Iii	METOPROLOL SUCCINATE	metoprolol succinate	TABLET, EXTENDED RELEASE;ORAL	205541-001	Nov 6, 2020	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Hetero Labs Ltd Iii	ATAZANAVIR SULFATE	atazanavir sulfate	CAPSULE;ORAL	212278-002	Feb 2, 2022	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Hetero Labs Ltd V	TOLTERODINE TARTRATE	tolterodine tartrate	TABLET;ORAL	204397-001	Aug 2, 2021	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for HETERO LABS drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.